FTSE 100 slides for fifth session as pharma shares drop
For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window
FTSE 100 down 0.3%, FTSE 250 down 0.2%
UK construction growth slows despite housing drive
ASOS soars as it sees core profit at top end of expectations
Pharma shares mark biggest one-day fall in near seven months
Updated at 1547 GMT
By Khushi Singh
Sept 5 (Reuters) -Britain's benchmark FTSE 100 stock index ended lower on Thursday, weighed by a decline in pharma shares, while a handful of stocks traded ex-dividend, adding to losses.
The blue-chip index .FTSE closed down 0.3%, falling for the fifth consecutive session for the first time since May.
The domestically-focused mid-cap FTSE 250 .FTMC index lost 0.2%, after touching a nearly one-month low on Wednesday.
The pharma and biotech index .FTNMX201030 was the biggest sector loser, tumbling 2.9% as drugmaker AstraZeneca AZN.L sank 3.9%.
Police in China have detained five current and former AstraZeneca employees for questioning about potential illegal activities, Bloomberg News reported, citing people familiar with the matter.
Primark owner AB Foods ABF.L was the top FTSE 100 loser, down 8.5% after the company said it expected Primark's like-for-like sales to decrease by 0.5% in second half of the year due to the unfavourable weather in Britain and Ireland.
Insurers Prudential PRU.L and Admiral ADML.L, paper and packaging firm DS Smith SMDS.L, and chemicals group Croda CRDA.L fell between 1.6% and 3.3% on trading ex-dividend.
In contrast, the homebuilders index .FTNMX402020 was the top sector performer, rising 2.6% after Vistry VTYV.L announced a share buyback worth 130 million pounds ($171 million) following a rise in half-year earnings. Vistry shares rose 8.5% to the top of FTSE 100.
Among mid-caps, Alfa Financial Software ALFAAL.L rose 10.3% rise after saying it expected full-year revenue to be 1 million pounds ahead of previous expectations.
Online retailer ASOS ASOS.L jumped 18.1% after forecasting adjusted core profit at the top end of market forecasts.
On the data front, growth in Britain's construction industry slowed in August despite the biggest pickup in homebuilding in nearly two years, adding to signs of easing inflation pressures.
British companies expect to raise selling prices by the smallest amount in nearly three years but wage growth shows no sign of cooling, another survey showed.
Reporting by Khushi Singh, Ankika Biswas in Bengaluru; Editing by Varun H K and Mark Potter
For related prices, Reuters users may click on - *
UK stock report .L
FTSE index: 0#.FTS6
techMARK 100 index: .FTT1X FTSE futures: 0#FFI:
Gilt futures: 0#FLG: Smallcap index: .FTSC
FTSE 250 index: .FTMC FTSE 350 index: .FTLC
Market digest: .AD.L Top 10 by vol: .AV.L
Top price gainers: .NG.L Top % gainers: .PG.L
Top price losers: .NL.L Top % losers: .PL.L
* For related news, click on - *
UK hot stocks: HOT and GB Wall Street: .N
Gilts report: GB/ Euro bond report GVD/EUR
Pan European stock report: .EU
Tokyo stocks: .T HK stocks: .HK
Sterling report: GBP/ Dollar report: USD/
* For company prices, click on - *
Company directory: UKEQ By sector: FTAX
* For pan-European market data, click on - *
European Equities speed guide................ EUR/EQUITY
FTSE Eurotop 300 index........................... .FTEU3
DJ STOXX index................................... .STOXX
Top 10 STOXX sectors........................ .PGL.STOXXS
Top 10 EUROSTOXX sectors................... .PGL.STOXXES
Top 10 Eurotop 300 sectors.................. .PGL.FTEU3S
Top 25 European pct gainers.................... .PG.PEUR
Top 25 European pct losers..................... .PL.PEUR
Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
